• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

昼夜节律与老年人较高的β-淀粉样蛋白和tau蛋白水平以及较差的认知能力有关。

Circadian rhythms are associated with higher amyloid-β and tau and poorer cognition in older adults.

作者信息

Eckhardt Joanna L, Isenberg Lisette, Aslanyan Vahan, Monreal Teresa, Stradford Joy, Fenton Laura, Contreras Joey A, Mack Wendy J, Pa Judy

机构信息

Alzheimer's Disease Cooperative Study (ADCS), Department of Neurosciences, University of California, San Diego, La Jolla, CA 92093, USA.

Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA 90007, USA.

出版信息

Brain Commun. 2025 Sep 8;7(5):fcaf322. doi: 10.1093/braincomms/fcaf322. eCollection 2025.

DOI:10.1093/braincomms/fcaf322
PMID:40926975
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12416565/
Abstract

Several studies implicate circadian rhythm disturbances in Alzheimer's disease. However, very little is known about how circadian rhythms are associated with Alzheimer's pathological biomarkers in older adults at early stages of the disease, and how these relationships map onto cognition. This cross-sectional study used 24-h accelerometry data to investigate the relationships between circadian rhythms, amyloid-β (Aβ), tau, and cognition in 68 older adults with objective early cognitive impairment. Participants wore GENEActiv accelerometers for ∼1 month (mean = 31.8 days). Circadian rhythms measures were quantified from accelerometer data and included acrotime (average time of day of peak activity) and intradaily variability (IV) (average circadian rhythm fragmentation within a day). Aβ was measured as a composite, and tau ( = 67) was measured in Braak staging regions of interest I/II and III/IV using positron emission tomography. The cognitive domains used were verbal memory (California Verbal Learning Test short delay free recall) and attention/processing speed (Digit Symbol Substitution Test). Multivariable linear regression models were conducted to test for associations between circadian rhythms and the outcome variables of Aβ, tau, and cognition. The moderating effects of age, sex, and () carrier status were assessed in these associations. To investigate mechanistic pathways through which circadian rhythms may impact cognition, exploratory mediation analyses were conducted . Models were adjusted for age, sex, carrier status, and years of education. The study included 68 older adults (mean age = 66.8 years, age range = 55-80 years, 63.2% female, 26.5% carriers). Earlier acrotime was associated with higher Aβ and tau, the former of which was stronger in carriers relative to non-carriers. Higher IV was related to higher tau in Braak regions III/IV. Age and sex modified the association between IV and tau, in which the relationships strengthened with increasing age and disproportionately affected men. Earlier acrotime was associated with worse verbal memory, but later acrotime was associated with worse attention/processing speed. Tau in Braak regions I-IV mediated the relationship between acrotime and verbal memory. The insights from this study revealed that circadian rhythms were associated with Aβ, tau, and cognition in older adults with objective early cognitive impairment. We provide novel evidence for tau as a biological mediator in the relationship between circadian timing and cognition. This work identified circadian rhythms as a promising point of intervention to reduce Alzheimer's disease risk and potentially mitigate pathological progression and cognitive decline.

摘要

多项研究表明昼夜节律紊乱与阿尔茨海默病有关。然而,对于昼夜节律在疾病早期阶段如何与老年人阿尔茨海默病病理生物标志物相关联,以及这些关系如何映射到认知方面,我们知之甚少。这项横断面研究使用24小时加速度计数据,调查了68名有客观早期认知障碍的老年人的昼夜节律、淀粉样蛋白β(Aβ)、tau蛋白与认知之间的关系。参与者佩戴GENEActiv加速度计约1个月(平均 = 31.8天)。从加速度计数据中量化昼夜节律指标,包括活动峰值时间(一天中活动峰值的平均时间)和日内变异性(IV)(一天内平均昼夜节律碎片化程度)。Aβ作为一个综合指标进行测量,tau蛋白(n = 67)使用正电子发射断层扫描在Braak分期感兴趣区域I/II和III/IV进行测量。所使用的认知领域包括言语记忆(加利福尼亚言语学习测试短延迟自由回忆)和注意力/处理速度(数字符号替换测试)。进行多变量线性回归模型以测试昼夜节律与Aβ、tau蛋白和认知结果变量之间的关联。在这些关联中评估了年龄、性别和载脂蛋白E(APOE)携带者状态的调节作用。为了研究昼夜节律可能影响认知的机制途径,进行了探索性中介分析。模型针对年龄、性别、APOE携带者状态和受教育年限进行了调整。该研究纳入了68名老年人(平均年龄 = 66.8岁,年龄范围 = 55 - 80岁,63.2%为女性,26.5%为APOE携带者)。较早的活动峰值时间与较高的Aβ和tau蛋白相关,其中前者在APOE携带者中相对于非携带者更强。较高的IV与Braak区域III/IV中较高的tau蛋白相关。年龄和性别改变了IV与tau蛋白之间的关联,其中这种关系随着年龄增长而增强,且对男性影响更大。较早的活动峰值时间与较差的言语记忆相关,但较晚的活动峰值时间与较差的注意力/处理速度相关。Braak区域I - IV中的tau蛋白介导了活动峰值时间与言语记忆之间的关系。这项研究的见解表明,昼夜节律与有客观早期认知障碍的老年人的Aβ、tau蛋白和认知相关。我们提供了新的证据,证明tau蛋白是昼夜节律与认知关系中的生物中介。这项工作确定昼夜节律是降低阿尔茨海默病风险、潜在减轻病理进展和认知衰退的一个有前景的干预点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c154/12416565/93bb827bbce2/fcaf322f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c154/12416565/65ae7eb7042d/fcaf322_ga.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c154/12416565/5eaff193422b/fcaf322f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c154/12416565/d3c57b9c0b87/fcaf322f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c154/12416565/d12a07c0cdc5/fcaf322f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c154/12416565/96c6b36b662d/fcaf322f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c154/12416565/93bb827bbce2/fcaf322f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c154/12416565/65ae7eb7042d/fcaf322_ga.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c154/12416565/5eaff193422b/fcaf322f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c154/12416565/d3c57b9c0b87/fcaf322f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c154/12416565/d12a07c0cdc5/fcaf322f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c154/12416565/96c6b36b662d/fcaf322f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c154/12416565/93bb827bbce2/fcaf322f5.jpg

相似文献

1
Circadian rhythms are associated with higher amyloid-β and tau and poorer cognition in older adults.昼夜节律与老年人较高的β-淀粉样蛋白和tau蛋白水平以及较差的认知能力有关。
Brain Commun. 2025 Sep 8;7(5):fcaf322. doi: 10.1093/braincomms/fcaf322. eCollection 2025.
2
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
APOE4 impact on soluble and insoluble tau pathology is mostly influenced by amyloid-beta.载脂蛋白E4(APOE4)对可溶性和不溶性tau蛋白病理的影响主要受β-淀粉样蛋白的影响。
Brain. 2025 Jan 16. doi: 10.1093/brain/awaf016.
5
Pulse pressure as a predictor of Alzheimer's disease biomarkers and cognitive decline: The moderating role of APOE ε4.脉压作为阿尔茨海默病生物标志物和认知衰退的预测指标:APOE ε4的调节作用
J Prev Alzheimers Dis. 2025 Sep 3:100363. doi: 10.1016/j.tjpad.2025.100363.
6
Timeline to symptomatic Alzheimer's disease in people with Down syndrome as assessed by amyloid-PET and tau-PET: a longitudinal cohort study.淀粉样蛋白 PET 和 tau-PET 评估唐氏综合征患者症状性阿尔茨海默病的时间轴:一项纵向队列研究。
Lancet Neurol. 2024 Dec;23(12):1214-1224. doi: 10.1016/S1474-4422(24)00426-5.
7
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
8
Circadian disturbances in Alzheimer's disease progression: a prospective observational cohort study of community-based older adults.阿尔茨海默病进展中的昼夜节律紊乱:一项基于社区老年人的前瞻性观察队列研究。
Lancet Healthy Longev. 2020 Dec;1(3):e96-e105. doi: 10.1016/s2666-7568(20)30015-5. Epub 2020 Nov 12.
9
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
10
Recent advances in the detection and management of motor dysfunction in Alzheimer's disease.阿尔茨海默病运动功能障碍检测与管理的最新进展
Psychiatriki. 2025 May 14. doi: 10.22365/jpsych.2025.012.

本文引用的文献

1
Abnormalities of Rest-Activity and Light Exposure Rhythms Associated with Cognitive Function in Patients with Mild Cognitive Impairment (MCI).轻度认知障碍(MCI)患者静息 - 活动及光照节律异常与认知功能的关系
J Circadian Rhythms. 2023 Dec 28;21:4. doi: 10.5334/jcr.227. eCollection 2023.
2
The Use of Tau PET to Stage Alzheimer Disease According to the Braak Staging Framework.使用 Tau PET 根据 Braak 分期框架分期阿尔茨海默病。
J Nucl Med. 2023 Aug;64(8):1171-1178. doi: 10.2967/jnumed.122.265200. Epub 2023 Jun 15.
3
Variability in objective sleep is associated with Alzheimer's pathology and cognition.
客观睡眠的变异性与阿尔茨海默病病理学及认知相关。
Brain Commun. 2023 Feb 16;5(2):fcad031. doi: 10.1093/braincomms/fcad031. eCollection 2023.
4
Circadian rest-activity rhythm and longitudinal brain changes underlying late-life cognitive decline.昼夜节律的休息-活动节律与晚年认知衰退的大脑纵向变化。
Psychiatry Clin Neurosci. 2023 Apr;77(4):205-212. doi: 10.1111/pcn.13521. Epub 2023 Jan 4.
5
Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline.淀粉样蛋白和 tau 正电子发射断层扫描(PET)阳性、认知正常的个体未来认知能力下降的风险较高。
Nat Med. 2022 Nov;28(11):2381-2387. doi: 10.1038/s41591-022-02049-x. Epub 2022 Nov 10.
6
Association of Elevated Amyloid and Tau Positron Emission Tomography Signal With Near-Term Development of Alzheimer Disease Symptoms in Older Adults Without Cognitive Impairment.在认知功能正常的老年人中,淀粉样蛋白和tau 正电子发射断层扫描信号升高与近期阿尔茨海默病症状的发展相关。
JAMA Neurol. 2022 Oct 1;79(10):975-985. doi: 10.1001/jamaneurol.2022.2379.
7
The Change in Circadian Rhythms in P301S Transgenic Mice is Linked to Variability in Hsp70-related Tau Disaggregation.P301S转基因小鼠昼夜节律的变化与Hsp70相关的tau蛋白解聚的变异性有关。
Exp Neurobiol. 2022 Jun 30;31(3):196-207. doi: 10.5607/en22019.
8
Registration of 24-hour accelerometric rest-activity profiles and its application to human chronotypes.24小时加速度计静息-活动图谱的记录及其在人类昼夜节律类型中的应用。
Biol Rhythm Res. 2022;53(8):1299-1319. doi: 10.1080/09291016.2021.1929673. Epub 2022 May 31.
9
Rest-activity rhythms and cognitive impairment and dementia in older women: Results from the Women's Health Initiative.老年人的静息-活动节律与认知障碍和痴呆:来自妇女健康倡议的结果。
J Am Geriatr Soc. 2022 Oct;70(10):2925-2937. doi: 10.1111/jgs.17926. Epub 2022 Jun 16.
10
APOE ε4, Alzheimer's disease neuropathology and sleep disturbance, in individuals with and without dementia.载脂蛋白 E ε4、阿尔茨海默病神经病理学与睡眠障碍,在痴呆与非痴呆个体中。
Alzheimers Res Ther. 2022 Mar 30;14(1):47. doi: 10.1186/s13195-022-00992-y.